Sept 25 (Reuters) - Radius Health Inc RDUS.O :
* RADIUS HEALTH & MENARINI GROUP PROVIDE ELACESTRANT UPDATE
* RADIUS HEALTH INC - TARGET ENROLLMENT MILESTONE REACHED IN PHASE 3 EMERALD STUDY
* RADIUS HEALTH INC - LIFE CYCLE PLANNING ADVANCING IN PARALLEL WITH CURRENT PHASE 3 MONOTHERAPY PROGRAM
* RADIUS HEALTH INC - IDMC RECOMMENDED THAT TRIAL CONTINUES TO ADVANCE IN AN UNMODIFIED MANNER
* RADIUS HEALTH INC - ANALYSIS OF PRIMARY ENDPOINT OF STUDY IS ANTICIPATED WILL TAKE PLACE IN SECOND HALF OF 2021